Caveats for triple-H therapy in the management of vasospasm after aneurysmal subarachnoid hemorrhage.
Matthew A
MA
Hunt
Anish
A
Bhardwaj
D002560:Cerebrovascular Circulation / Q000187:drug effects; D006438:Hemodilution / Q000009:adverse effects; D006801:Humans; D010952:Plasma Substitutes / Q000009:adverse effects / Q000627:therapeutic use*; D013345:Subarachnoid Hemorrhage / Q000628:therapy*; D014662:Vasoconstrictor Agents / Q000009:adverse effects / Q000627:therapeutic use*; D020301:Vasospasm, Intracranial / Q000628:therapy*
D010952:Plasma Substitutes; D014662:Vasoconstrictor Agents